Cargando…
HKDC1 Silencing Inhibits Proliferation and Glycolysis of Gastric Cancer Cells
Gastric cancer (GC) is the third most lethal and fifth most common cancer in the world. In a variety of cancers, the hexokinase domain component 1 (HKDC1) is carcinogenic. This study was to investigate into how HKDC1 contributes to the development and progression of GC. Three different datasets (GSE...
Autores principales: | Yu, Chen, Bao, Ting-ting, Jin, Li, Lu, Jian-wei, Feng, Ji-feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162881/ https://www.ncbi.nlm.nih.gov/pubmed/37153834 http://dx.doi.org/10.1155/2023/3876342 |
Ejemplares similares
-
HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer
por: Wang, Mei‐Qian, et al.
Publicado: (2023) -
HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway
por: Wang, Xinyu, et al.
Publicado: (2020) -
The hexokinase “HKDC1” interaction with the mitochondria is essential for liver cancer progression
por: Khan, Md. Wasim, et al.
Publicado: (2022) -
Silencing of ENO1 by shRNA Inhibits the Proliferation of Gastric Cancer
Cells
por: Qiao, Hui, et al.
Publicado: (2018) -
HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression
por: Chen, Qi, et al.
Publicado: (2020)